Garakani, Amir <br/><br/>
A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.  [electronic resource] 

 -  International clinical psychopharmacology  Sep 2008 
 - 269-75 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-1315 
<br/><br/><label>Standard No.: </label>10.1097/YIC.0b013e328301a74c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antidepressive Agents, Second-Generation--therapeutic use<br/>Antipsychotic Agents--therapeutic use<br/>Depressive Disorder, Major--drug therapy<br/>Dibenzothiazepines--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Fluoxetine--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Psychiatric Status Rating Scales<br/>Quetiapine Fumarate<br/>Regression Analysis<br/>Treatment Outcome